The team approach to patient care

Published Date: 08 Mar 2023

Encouraging doctors to work as a team on data development and patient care could be one way to improve the condition of stressed GPs, according to a new study.

Read Full News

Latest News

Satralizumab Shows Promise for Thyroid Eye Disease

An antibody targeting the interleukin-6 receptor may help reduce bulging of the eyes and inflammation in patients with thyroid eye disease, early phase 3 data show.

Retinal Reflections: Sustained Delivery in Retinal Vascular Disease-From Evidence to Implementation

Retinal Reflections: Sustained Delivery in Retinal Vascular Disease-From Evidence to Implementation

Mechanisms That Matter: Understanding Intravitreal Therapies for Retinal Vascular Diseases

Mechanisms That Matter: Understanding Intravitreal Therapies for Retinal Vascular Diseases

Eye Specialists Flag Concerns About Pricey Lenses in Cataract Surgery

Multifocal lenses are not for everyone, experts say

Anti-VEGF Agent Collects Big Win in Trial of Diabetic Retinopathy

More than 60% of tarcocimab-treated patients had reduced severity

New Agents for AMD Preserve Vision, Dramatically Reduce Treatment Burden

Bispecific antibody fares well against faricimab, two gene therapies extend treatment intervals

Todays Updates

Osimertinib's OS Benefit in Resected NSCLC Persists 8 Years

Even years after treatment ends, adjuvant osimertinib brings an overall survival benefit to patients with resected EGFR-mutated lung cancer.

Pelvic RT Tied to Longer Survival in Cervical Cancer

In patients with newly diagnosed stage IVB cervical cancer, adding definitive-dose pelvic radiotherapy to chemotherapy was associated with longer survival compared with chemotherapy alone.

New Data Put ADCs on the Map in Relapsed SCLC

Two B7-H3-directed antibody-drug conjugates substantially improve survival over topotecan among patients with relapsed small cell lung cancer — pointing to a potential new treatment class.

Real-World Liso-Cel Results in MCL Consistent With Trials

Two analyses of liso-cel CAR T-cell therapy in relapsed or refractory mantle cell lymphoma show response rates in the real-world setting similar to those seen in clinical trial populations.

Antibiotic Use in Hospice Linked to Higher Mortality Risk

Antibiotic use in patients under hospice care is associated with an increased risk for mortality; for infectious hospice-qualifying conditions, antibiotic use is linked to extended survival.

Todays Updates

Osimertinib's OS Benefit in Resected NSCLC Persists 8 Years

Even years after treatment ends, adjuvant osimertinib brings an overall survival benefit to patients with resected EGFR-mutated lung cancer.

Pelvic RT Tied to Longer Survival in Cervical Cancer

In patients with newly diagnosed stage IVB cervical cancer, adding definitive-dose pelvic radiotherapy to chemotherapy was associated with longer survival compared with chemotherapy alone.

New Data Put ADCs on the Map in Relapsed SCLC

Two B7-H3-directed antibody-drug conjugates substantially improve survival over topotecan among patients with relapsed small cell lung cancer — pointing to a potential new treatment class.

Real-World Liso-Cel Results in MCL Consistent With Trials

Two analyses of liso-cel CAR T-cell therapy in relapsed or refractory mantle cell lymphoma show response rates in the real-world setting similar to those seen in clinical trial populations.

Antibiotic Use in Hospice Linked to Higher Mortality Risk

Antibiotic use in patients under hospice care is associated with an increased risk for mortality; for infectious hospice-qualifying conditions, antibiotic use is linked to extended survival.

Latest News

An antibody targeting the interleukin-6 receptor may help reduce bulging of the eyes and inflammation in patients with thyroid eye disease, early phase 3 data show.

Retinal Reflections: Sustained Delivery in Retinal Vascular Disease-From Evidence to Implementation

Mechanisms That Matter: Understanding Intravitreal Therapies for Retinal Vascular Diseases

Multifocal lenses are not for everyone, experts say

More than 60% of tarcocimab-treated patients had reduced severity

Bispecific antibody fares well against faricimab, two gene therapies extend treatment intervals

News All Time

EyePoint's Drug for Age-related Eye Disease Fails Late-stage Trial, Shares Tank

EyePoint said its experimental drug missed the main goal in a late-stage trial as a few patients lost vision ⁠from causes unrelated to the targeted disease, sending its...

Massage Matches Clinic Probing for Infant Tear Duct Blockage

Gently massaging the tear sacs of infants with blocked tear ducts may be as effective as clinic-based probing for clearing tearing and discharge, a noninferiority trial finds.

Can Dexamethasone Drops Prevent Retinal Disease in Preemies?

Dexamethasone eye drops administered in premature infants with early-stage retinal disease appear to reduce the odds of progression to treatment-requiring disease.

Urinary Drug Tadalafil Linked to Glaucoma Risk

Men taking tadalafil for lower urinary tract symptoms face a 22% higher risk of developing glaucoma than those who do not take the drug, a new study finds.

Study Links Uveitis to Higher Risk for Psychiatric Illness

Noninfectious uveitis is linked to higher rates of psychiatric comorbidities, with Black patients most affected, a new study finds.

Nonvalved Drainage Device Benefits Kids With Glaucoma

In children with difficult-to-treat glaucoma, a nonvalved implant yields sustained reductions in intraocular pressure and medication burden for up to 5 years.

What Is Causing Progressive Vision Problems in a 32-Year-Old Woman?

A glaucoma diagnosis at a young age should prompt timely genetic testing

Woman Develops Chorioretinal Anastomosis at Site of Photocoagulation Scar

A serendipitous iatrogenic effect following laser surgery in a patient with NF1

Sustained Strategies in Retina: Advancing Long-Acting Therapies for Retinal Vascular Disease

Sustained Strategies in Retina: Advancing Long-Acting Therapies for Retinal Vascular Disease

Focus Refined: Applying Emerging Evidence in Pharmacologic Presbyopia Management

Focus Refined: Applying Emerging Evidence in Pharmacologic Presbyopia Management

Real Retinal Decisions: A Clinical Case Challenge in Personalized Retinal Vascular Disease Treatment

Real Retinal Decisions: A Clinical Case Challenge in Personalized Retinal Vascular Disease Treatment

GLP-1 Drug Linked to Cases of Rare Vision-Altering Condition

Resolution occurred after stopping dulaglutide, no obvious clues to mechanism

What Caused Visual Disturbance in Kidney Transplant Patient?

Genetic testing identified PAX2 gene variant

Floaters Affect Vision of Kidney Transplant Patient

UL97- and UL54-resistant CMV retinitis treated with multivirus-specific T-cell therapy

Massage Gun Eye Injury: Retinal Tears, Detachment

'Hesitant historian' did not initially disclose that he used the product on his eyes

AI Smart Glasses Show Promise, Limitations as Aid for Patients With Low Vision

Good accuracy for recognizing common objects, mixed results by object size, colors, text, money

Recommended News For You

Adding Daratumumab to VRd Boosts MRD Negativity in Transplant-Ineligible Myeloma

Cancer Diagnoses Slow to Recover From Effects of COVID Pandemic

Addition of regional nodal irradiation does not decrease rates of invasive breast cancer recurrence, study finds

Kekoa Taparra, a native Hawaiian physician-scientist, is becoming well-known.

Scientists develop novel adjuvant delivery system to enhance cancer vaccine effectiveness

Guideline on management of early-stage non-small cell lung cancer released

Global warming could be driving up women's cancer risk, find researchers

Recommended Articles For You

Simulation for Hematology Emergencies: Enhancing Clinical Preparedness and Patient Outcomes 

Modern Updates in Hematology in the Digital Era 

Decoding Granular Cell Tumor: What You Need to Know 

How is Digital Innovation Revolutionizing Gynecologic Oncology Treatment and Patient Engagement? 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

High Success Rate With Conversion Therapy for Unresectable Gastroesophageal Cancer

2.

Time to Rethink Maintenance Pemetrexed in NSCLC?

3.

Having dense breasts is linked to cancer, but advice about breast density can depend on where you live

4.

findings from the measurement of disability weights in China with an emphasis on the impact of disease burden.

5.

Racial differences seen in epigenetic age acceleration in childhood cancer survivors

1.

The Predictive Power of Targeted Radionuclide Therapy in Advanced Breast Cancer

2.

Next-Generation Sequencing in Oncology: Unlocking the Future of Precision Medicine

3.

Navigating the Unknown: A Guide to Living With Hurthle Cell Thyroid Cancer

4.

Molecular & Genetic Oncology: Emerging Frontiers in 2025

5.

Surgical Innovation Through Bone Marrow–Reserving Surgical Strategies

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know

2.

Innovations in Hematology

3.

Should We Use DARA Up Front As First-Line Therapy in MM?

4.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)

5.

The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot